C N Ford1, R W Leet1,2, L M Kipling1, M K Rhee3,4, S L Jackson5, P W F Wilson3,4,6, L S Phillips3,4, L R Staimez1,2. 1. Emory Global Diabetes Research Centre, Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA. 2. Nutrition and Health Sciences, Rollins School of Public Health, Emory University, Atlanta, GA, USA. 3. Atlanta VA Medical Centre, Decatur, GA, USA. 4. Division of Endocrinology and Metabolism, Department of Medicine, Emory University, Atlanta, GA, USA. 5. Division for Heart Disease and Stroke Prevention, National Centre for Chronic Disease Prevention and Health Promotion, Centres for Disease Control and Prevention, Atlanta, GA, USA. 6. Division of Cardiology, Department of Medicine, School of Medicine, Emory University, Atlanta, GA, USA.
Abstract
AIM: To characterize differences between black and white people in optimal HbA1c thresholds for diagnoses of diabetes and prediabetes. METHODS: Data were included from the National Health and Nutrition Examination Survey, 2005-2014. Black and white adults (age 18-70 years) who underwent an oral glucose tolerance test and had available fasting plasma glucose, 2-h plasma glucose and HbA1c measurements were eligible for inclusion. Diabetes or prediabetes status was defined by fasting plasma glucose and 2-h plasma glucose using American Diabetes Association criteria. Classification of diabetes, prediabetes and dysglycaemia by HbA1c was evaluated for a range of HbA1c thresholds, with optimal thresholds defined as those values that maximized the sum of sensitivity and specificity (Youden's index). RESULTS: In 5324 black (32.3%) and white (67.7%) individuals, Youden's index (optimal) thresholds for HbA1c were ≥42 mmol/mol (6.0%) and ≥39 mmol/mol (5.7%) for discriminating diabetes vs non-diabetes, ≥ 44 mmol/mol (6.2%) and ≥39 mmol/mol (5.7%) for discriminating diabetes vs prediabetes (excluding normoglycaemia), ≥39 mmol/mol (5.7%) and ≥37 mmol/mol (5.5%) for discriminating dysglycaemia vs normoglycaemia, and ≥39 mmol/mol (5.7%) and ≥37 mmol/mol (5.5%) for discriminating prediabetes vs normoglycaemia (excluding diabetes), in black and white people, respectively. CONCLUSIONS: Consistently higher optimal HbA1c thresholds in black people than in white people suggest a need to individualize HbA1c relative to glucose levels if HbA1c is used to diagnose diabetes and prediabetes.
AIM: To characterize differences between black and white people in optimal HbA1c thresholds for diagnoses of diabetes and prediabetes. METHODS: Data were included from the National Health and Nutrition Examination Survey, 2005-2014. Black and white adults (age 18-70 years) who underwent an oral glucose tolerance test and had available fasting plasma glucose, 2-h plasma glucose and HbA1c measurements were eligible for inclusion. Diabetes or prediabetes status was defined by fasting plasma glucose and 2-h plasma glucose using American Diabetes Association criteria. Classification of diabetes, prediabetes and dysglycaemia by HbA1c was evaluated for a range of HbA1c thresholds, with optimal thresholds defined as those values that maximized the sum of sensitivity and specificity (Youden's index). RESULTS: In 5324 black (32.3%) and white (67.7%) individuals, Youden's index (optimal) thresholds for HbA1c were ≥42 mmol/mol (6.0%) and ≥39 mmol/mol (5.7%) for discriminating diabetes vs non-diabetes, ≥ 44 mmol/mol (6.2%) and ≥39 mmol/mol (5.7%) for discriminating diabetes vs prediabetes (excluding normoglycaemia), ≥39 mmol/mol (5.7%) and ≥37 mmol/mol (5.5%) for discriminating dysglycaemia vs normoglycaemia, and ≥39 mmol/mol (5.7%) and ≥37 mmol/mol (5.5%) for discriminating prediabetes vs normoglycaemia (excluding diabetes), in black and white people, respectively. CONCLUSIONS: Consistently higher optimal HbA1c thresholds in black people than in white people suggest a need to individualize HbA1c relative to glucose levels if HbA1c is used to diagnose diabetes and prediabetes.
Authors: Richard M Bergenstal; Robin L Gal; Crystal G Connor; Rose Gubitosi-Klug; Davida Kruger; Beth A Olson; Steven M Willi; Grazia Aleppo; Ruth S Weinstock; Jamie Wood; Michael Rickels; Linda A DiMeglio; Kathleen E Bethin; Santica Marcovina; Andreana Tassopoulos; Sooji Lee; Elaine Massaro; Suzan Bzdick; Brian Ichihara; Eileen Markmann; Paul McGuigan; Stephanie Woerner; Michelle Ecker; Roy W Beck Journal: Ann Intern Med Date: 2017-06-13 Impact factor: 25.391
Authors: James M Hempe; Shuqian Liu; Leann Myers; Robert J McCarter; John B Buse; Vivian Fonseca Journal: Diabetes Care Date: 2015-04-17 Impact factor: 19.112
Authors: William H Herman; Yong Ma; Gabriel Uwaifo; Steven Haffner; Steven E Kahn; Edward S Horton; John M Lachin; Maria G Montez; Tina Brenneman; Elizabeth Barrett-Connor Journal: Diabetes Care Date: 2007-05-29 Impact factor: 19.112
Authors: Yusuke Tsugawa; Kenneth J Mukamal; Roger B Davis; William C Taylor; Christina C Wee Journal: Ann Intern Med Date: 2012-08-07 Impact factor: 25.391
Authors: Kasia J Lipska; Joseph S Ross; Yun Wang; Silvio E Inzucchi; Karl Minges; Andrew J Karter; Elbert S Huang; Mayur M Desai; Thomas M Gill; Harlan M Krumholz Journal: JAMA Intern Med Date: 2014-07 Impact factor: 21.873
Authors: Mary E Lacy; Gregory A Wellenius; Anne E Sumner; Adolfo Correa; Mercedes R Carnethon; Robert I Liem; James G Wilson; David B Sacks; David R Jacobs; April P Carson; Xi Luo; Annie Gjelsvik; Alexander P Reiner; Rakhi P Naik; Simin Liu; Solomon K Musani; Charles B Eaton; Wen-Chih Wu Journal: JAMA Date: 2017-02-07 Impact factor: 157.335
Authors: Eleanor Wheeler; Aaron Leong; Ching-Ti Liu; Marie-France Hivert; Rona J Strawbridge; Clara Podmore; Man Li; Jie Yao; Xueling Sim; Jaeyoung Hong; Audrey Y Chu; Weihua Zhang; Xu Wang; Peng Chen; Nisa M Maruthur; Bianca C Porneala; Stephen J Sharp; Yucheng Jia; Edmond K Kabagambe; Li-Ching Chang; Wei-Min Chen; Cathy E Elks; Daniel S Evans; Qiao Fan; Franco Giulianini; Min Jin Go; Jouke-Jan Hottenga; Yao Hu; Anne U Jackson; Stavroula Kanoni; Young Jin Kim; Marcus E Kleber; Claes Ladenvall; Cecile Lecoeur; Sing-Hui Lim; Yingchang Lu; Anubha Mahajan; Carola Marzi; Mike A Nalls; Pau Navarro; Ilja M Nolte; Lynda M Rose; Denis V Rybin; Serena Sanna; Yuan Shi; Daniel O Stram; Fumihiko Takeuchi; Shu Pei Tan; Peter J van der Most; Jana V Van Vliet-Ostaptchouk; Andrew Wong; Loic Yengo; Wanting Zhao; Anuj Goel; Maria Teresa Martinez Larrad; Dörte Radke; Perttu Salo; Toshiko Tanaka; Erik P A van Iperen; Goncalo Abecasis; Saima Afaq; Behrooz Z Alizadeh; Alain G Bertoni; Amelie Bonnefond; Yvonne Böttcher; Erwin P Bottinger; Harry Campbell; Olga D Carlson; Chien-Hsiun Chen; Yoon Shin Cho; W Timothy Garvey; Christian Gieger; Mark O Goodarzi; Harald Grallert; Anders Hamsten; Catharina A Hartman; Christian Herder; Chao Agnes Hsiung; Jie Huang; Michiya Igase; Masato Isono; Tomohiro Katsuya; Chiea-Chuen Khor; Wieland Kiess; Katsuhiko Kohara; Peter Kovacs; Juyoung Lee; Wen-Jane Lee; Benjamin Lehne; Huaixing Li; Jianjun Liu; Stephane Lobbens; Jian'an Luan; Valeriya Lyssenko; Thomas Meitinger; Tetsuro Miki; Iva Miljkovic; Sanghoon Moon; Antonella Mulas; Gabriele Müller; Martina Müller-Nurasyid; Ramaiah Nagaraja; Matthias Nauck; James S Pankow; Ozren Polasek; Inga Prokopenko; Paula S Ramos; Laura Rasmussen-Torvik; Wolfgang Rathmann; Stephen S Rich; Neil R Robertson; Michael Roden; Ronan Roussel; Igor Rudan; Robert A Scott; William R Scott; Bengt Sennblad; David S Siscovick; Konstantin Strauch; Liang Sun; Morris Swertz; Salman M Tajuddin; Kent D Taylor; Yik-Ying Teo; Yih Chung Tham; Anke Tönjes; Nicholas J Wareham; Gonneke Willemsen; Tom Wilsgaard; Aroon D Hingorani; Josephine Egan; Luigi Ferrucci; G Kees Hovingh; Antti Jula; Mika Kivimaki; Meena Kumari; Inger Njølstad; Colin N A Palmer; Manuel Serrano Ríos; Michael Stumvoll; Hugh Watkins; Tin Aung; Matthias Blüher; Michael Boehnke; Dorret I Boomsma; Stefan R Bornstein; John C Chambers; Daniel I Chasman; Yii-Der Ida Chen; Yduan-Tsong Chen; Ching-Yu Cheng; Francesco Cucca; Eco J C de Geus; Panos Deloukas; Michele K Evans; Myriam Fornage; Yechiel Friedlander; Philippe Froguel; Leif Groop; Myron D Gross; Tamara B Harris; Caroline Hayward; Chew-Kiat Heng; Erik Ingelsson; Norihiro Kato; Bong-Jo Kim; Woon-Puay Koh; Jaspal S Kooner; Antje Körner; Diana Kuh; Johanna Kuusisto; Markku Laakso; Xu Lin; Yongmei Liu; Ruth J F Loos; Patrik K E Magnusson; Winfried März; Mark I McCarthy; Albertine J Oldehinkel; Ken K Ong; Nancy L Pedersen; Mark A Pereira; Annette Peters; Paul M Ridker; Charumathi Sabanayagam; Michele Sale; Danish Saleheen; Juha Saltevo; Peter Eh Schwarz; Wayne H H Sheu; Harold Snieder; Timothy D Spector; Yasuharu Tabara; Jaakko Tuomilehto; Rob M van Dam; James G Wilson; James F Wilson; Bruce H R Wolffenbuttel; Tien Yin Wong; Jer-Yuarn Wu; Jian-Min Yuan; Alan B Zonderman; Nicole Soranzo; Xiuqing Guo; David J Roberts; Jose C Florez; Robert Sladek; Josée Dupuis; Andrew P Morris; E-Shyong Tai; Elizabeth Selvin; Jerome I Rotter; Claudia Langenberg; Inês Barroso; James B Meigs Journal: PLoS Med Date: 2017-09-12 Impact factor: 11.069
Authors: Woolton Lee; Jennifer T Lloyd; Katherine Giuriceo; Timothy Day; William Shrank; Rahul Rajkumar Journal: Health Serv Res Date: 2020-07-27 Impact factor: 3.402